ACTIVE

THOMAS BROOS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

90,5 k €

-0.6% YoY

Gross margin

121,5 k €

-1.1% YoY

Equity

559,7 k €

-6.7% YoY

What does THOMAS BROOS do?

THOMAS BROOS is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Herent.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0822.320.765

Incorporation

14/01/2010

Legal form

Private limited company

Registered office

Termerestraat 2 box d
3020 Herent · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 12 financial years

	2025		2024		2023		2022		2021		2016		2015		2014		2013		2012		2011		2010
Income statement
Gross margin	121,5 k €	-1.1%	122,9 k €	+16.9%	105,1 k €	-7.8%	114 k €	+3.3%	110,3 k €	-23.0%	143,4 k €	+20.5%	119 k €	-10.8%	133,4 k €	+2.3%	130,3 k €	+71.3%	76,1 k €	+265%	20,8 k €	-29.0%	29,3 k €
EBITDA	120,3 k €	-1.2%	121,8 k €	+17.5%	103,6 k €	-8.3%	113 k €	+3.3%	109,4 k €	-22.9%	142 k €	+20.9%	117,4 k €	-10.6%	131,4 k €	+2.0%	128,8 k €	+72.0%	74,9 k €	+283%	19,6 k €	-29.9%	27,9 k €
Operating result	119,1 k €	-2.2%	121,8 k €	+17.5%	103,6 k €	-8.3%	113 k €	+4.9%	107,8 k €	-20.9%	136,4 k €	+20.3%	113,4 k €	-13.6%	131,3 k €	+2.3%	128,3 k €	+72.2%	74,5 k €	+288%	19,2 k €	-30.3%	27,5 k €
Net result	90,5 k €	-0.6%	91 k €	-5.8%	96,6 k €	-15.6%	114,5 k €	+36.1%	84,1 k €	+39.5%	60,3 k €	+18.6%	50,9 k €	-15.7%	60,3 k €	-4.6%	63,2 k €	+62.0%	39 k €	+184%	13,7 k €	-28.2%	19,1 k €
Balance sheet
Equity	559,7 k €	-6.7%	599,9 k €	+4.0%	576,8 k €	+4.0%	554,7 k €	+2.3%	542,2 k €	+70.8%	317,4 k €	+23.5%	257,1 k €	+24.7%	206,2 k €	+41.3%	145,9 k €	+76.4%	82,7 k €	+89.3%	43,7 k €	+45.9%	29,9 k €
Total assets	1,2 M €	+0.9%	1,2 M €	+2.3%	1,1 M €	-0.4%	1,2 M €	+0.4%	1,1 M €	-2.6%	1,2 M €	+1.7%	1,2 M €	-1.5%	1,2 M €	+1.7%	1,2 M €	+0.9%	1,1 M €	+1845%	59 k €	+31.4%	44,9 k €
Cash	45,6 k €	+31.9%	34,6 k €	+107%	16,7 k €	-23.3%	21,8 k €	-8.7%	23,9 k €	-22.3%	30,7 k €	+185%	10,8 k €	-38.8%	17,6 k €	-48.9%	34,5 k €	+53.0%	22,6 k €	-53.5%	48,5 k €	+45.3%	33,4 k €
Debts	611,7 k €	+9.0%	561,2 k €	-0.5%	564 k €	-4.9%	593,3 k €	-1.6%	603 k €	-29.9%	860,6 k €	-4.5%	901,3 k €	-7.1%	970,2 k €	-4.0%	1 M €	-5.0%	1,1 M €	+6952%	15,1 k €	+2.1%	14,8 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Thomas Broos

Bestuurder · since 14 janvier 2010

Active

Ended mandates

Lies De Waele

Bestuurder · since 01 janvier 2013

Ended

Lies De Waele

Director · since 01 janvier 2013

Ended

Lies De Waele

Manager · since 01 janvier 2013

Ended

Thomas Broos

Director · since 14 janvier 2010

Ended

At this address

Other companies at this address

Company	CBE no.
Bumbari● Active	0806.324.970
PHARMACARE● Active	0877.831.687

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/03/2026	28/02/2025	29/02/2024	20/03/2023	02/06/2022	22/07/2021
General meeting	25/02/2026	14/02/2025	16/02/2024	16/03/2023	28/05/2022	22/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	25/02/2026	23/03/2026	Dutch	PDF
Abridged model	31/12/2024	14/02/2025	28/02/2025	Dutch	PDF
Abridged model	31/12/2023	16/02/2024	29/02/2024	Dutch	PDF
Abridged model	31/12/2022	16/03/2023	20/03/2023	Dutch	PDF
Abridged model	31/12/2021	28/05/2022	02/06/2022	Dutch	PDF
Abridged model	31/12/2020	22/05/2021	22/07/2021	Dutch	PDF
Abridged model	31/12/2019	23/05/2020	28/08/2020	Dutch	PDF
Abridged model	31/12/2018	25/05/2019	30/07/2019	Dutch	PDF
Abridged model	31/12/2017	26/05/2018	25/07/2018	Dutch	PDF
Abridged model	31/12/2016	27/05/2017	20/06/2017	Dutch	PDF
Abridged model	31/12/2015	28/05/2016	14/06/2016	Dutch	PDF
Abridged model	31/12/2014	23/05/2015	13/07/2015	Dutch	PDF
Abridged model	31/12/2013	24/05/2014	16/06/2014	Dutch	PDF
Abridged model	31/12/2012	25/05/2013	05/07/2013	Dutch	PDF
Abridged model	31/12/2011	26/05/2012	23/06/2012	Dutch	PDF
Abridged model	31/12/2010	28/05/2011	27/06/2011	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Thomas Broos

Bestuurder · since 14 janvier 2010

Active

Ended mandates

Lies De Waele

Bestuurder · since 01 janvier 2013

Ended

Lies De Waele

Director · since 01 janvier 2013

Ended

Lies De Waele

Manager · since 01 janvier 2013

Ended

Thomas Broos

Director · since 14 janvier 2010

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/10/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/11/2022
ONTSLAGEN - BENOEMINGEN
PDF
Registered office24/12/2020
MAATSCHAPPELIJKE ZETEL
PDF
Mandates14/05/2013
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Other26/01/2010
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202590,5 k €↓
2024
Annual accounts 202491 k €↓
2023
Annual accounts 202396,6 k €↓
2022
Annual accounts 2022114,5 k €↑
2021
Annual accounts 202184,1 k €↑
2016
Annual accounts 201660,3 k €↑
2015
Annual accounts 201550,9 k €↓
2014
Annual accounts 201460,3 k €↓
2013
Annual accounts 201363,2 k €↑
2012
Annual accounts 201239 k €↑
2011
Annual accounts 201113,7 k €↓
2010
Annual accounts 201019,1 k €
14/01/2010
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

THOMAS BROOS

Overview

What does THOMAS BROOS do?

Trend over 12 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline